The Yorkshire Cancer Centre Appeal, part of The Leeds Hospital Charitable Foundation, is the fundraising arm of Leeds Cancer Centre at St James's Institute of Oncology (pictured left) and provides supplementary benefits; specialist medical equipment, research and development and patient ‘home comforts’.
Each day, the Institute has responsibility for treating 2,000 patients (from a catchment population of 2.6 million), most of whom will have had a cancer diagnosis.
Our appeal aims to supplement NHS budgets by purchasing those ‘extras’ to help ensure that our patients continue to receive the very best that this centre can provide.
A £10 million appeal was launched in 2007 immediately prior to the relocation of Oncology services to Bexley Wing, a target which was met in June 2016. The four stranded appeal was set up to provide funding towards specialist medical equipment, scientific research & development, patient ‘home comforts’ and arts and gardens projects. You can read more about the four strands of our appeal here.
To view our £10 Million Appeal Celebration video, and see just some of the ways in which the YCC has supported the Bexley Wing and the 2,000 patients treated at Leeds Cancer Centre every day, click here.
We're planning for the next ten years - aiming even higher, developing research and treatments to ensure more people survive cancer through prevention, early detection and diagnosis, treatment and aftercare.
With your help we can improve cancer outcomes for patients throughout Yorkshire as we continue to challenge this indiscriminate disease that still affects one in three lives in the UK.
Leeds Cancer Centre has established itself internationally as among the foremost in clinical innovation and expertise in oncology, supported significantly through its technological prowess. Access to this technology is in no small part due to the efforts of fundraising in all its forms by the Yorkshire Cancer Centre from its supporters and Charitable Trustees.
The passion of our clinicians and researchers for getting the best care for patients drives a continuous dialogue on what state-of-the art medical technologies are just over the horizon. The greatest need for cancer patients in Leeds is currently in keeping abreast with the radiotherapy service. A capital appeal to fund an MRi Simulator for specific use in the Radiotherapy Department has now been launched. Read More >>
We’re delighted to have reached anther fundraising milestone in 2016 - our £160k target to purchase a NanoKnife for patients at the cancer centre. We had the opportunity to thank our major donors last night when they attended a celebration event in Bexley Wing.
The NanoKnife offers an alternative treatment for tumours when surgery and radiotherapy are not possible. The Nanoknife is used to destroy inoperable tumours in the lungs, kidney, breast, prostate and pancreas. The revolutionary procedure uses special needles to fire electrical pulses into the cancer cell walls, destroying tumours. The treatment is non-invasive and patients experience few or no side effects and are able to leave hospital the next day. Read More >>
The eleven storey landmark building which cost £220 million was funded through the Private Finance Initiative (PFI*). It is one of the largest schemes for this part of Leeds for over a generation and the largest cancer centre in Europe.
*PFI - (Private Finance Initiative) private investment funds the design, building, financing and operation of the buildings
under a 30 year concession after which the assets revert to the NHS Trust as a gift.